Effective treatment of severe COVID-19 patients with tocilizumab

After analyzing the immune characteristics of patients with severe coronavirus disease 2019 (COVID-19), we have identified that pathogenic T cells and inflammatory monocytes with large amount of interleukin 6 secreting may incite the inflammatory storm, which may potentially be curbed through monocl...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Proc Natl Acad Sci U S A
Main Authors: Xu, Xiaoling, Han, Mingfeng, Li, Tiantian, Sun, Wei, Wang, Dongsheng, Fu, Binqing, Zhou, Yonggang, Zheng, Xiaohu, Yang, Yun, Li, Xiuyong, Zhang, Xiaohua, Pan, Aijun, Wei, Haiming
Formato: Artigo
Idioma:Inglês
Publicado em: National Academy of Sciences 2020
Assuntos:
Biological Sciences
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7245089/
https://ncbi.nlm.nih.gov/pubmed/32350134
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1073/pnas.2005615117
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados